Clarus Therapeutics Holdings, Inc.
CRXTDelisted Sep 14, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817944
Clarus Therapeutics Holdings, Inc. was delisted on Sep 14, 2022; its insiders filed their last Form 4 on Jun 9, 2022; 25 institutions reported holding it in 13F filings for Q2 2022, worth $1.82M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Clarus Therapeutics Holdings, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 12 | +12 |
| Shares | 0 | 2.26M | +2.26M |
| Value | $0 | $12.1M | +$12.1M |
New holders (12)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bracebridge Capital, LLC | 2,002,495 | $10.7M | 3.83% |
| Telemetry Investments, L.L.C. | 45,000 | $240.0K | 0.33% |
| Tower Research Capital LLC (TRC) | 43,345 | $231.0K | 0.01% |
| Powell Investment Advisors, LLC | 43,000 | $229.0K | 0.14% |
| UBS Group AG | 38,654 | $206.0K | 0.00% |
| Verition Fund Management LLC | 30,000 | $160.0K | 0.00% |
| Susquehanna International Group, LLP | 22,543 | $120.0K | 0.00% |
| Virtu Financial LLC | 17,704 | $94.0K | 0.01% |
| Cowen and Company, LLC | 10,000 | $53.0K | 0.00% |
| JPMorgan Chase & Co | 7,846 | $42.0K | 0.00% |
| Bank of America Corp | 100 | $1.00K | 0.00% |
| Royal Bank of Canada | 200 | $1.00K | 0.00% |
Sold out (0)
Institutions that held Clarus Therapeutics Holdings, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.